177 related articles for article (PubMed ID: 17357526)
1. California drug courts: outcomes, costs and promising practices: an overview of Phase II in a statewide study.
Carey SM; Finigan M; Crumpton D; Waller M
J Psychoactive Drugs; 2006 Nov; Suppl 3():345-56. PubMed ID: 17357526
[TBL] [Abstract][Full Text] [Related]
2. California drug courts: a methodology for determining costs and avoided costs.
Byrne F; Schauffler R; Lightman L; Finigan M; Carey S
J Psychoactive Drugs; 2004 May; Suppl 2():147-56. PubMed ID: 15279127
[TBL] [Abstract][Full Text] [Related]
3. Drug court effectiveness: a review of California evaluation reports, 1995-1999.
Guydish J; Wolfe E; Tajima B; Woods WJ
J Psychoactive Drugs; 2001; 33(4):369-78. PubMed ID: 11824696
[TBL] [Abstract][Full Text] [Related]
4. Lifting the cover on drug courts: evaluation findings and policy concerns.
Sanford JS; Arrigo BA
Int J Offender Ther Comp Criminol; 2005 Jun; 49(3):239-59. PubMed ID: 15851506
[TBL] [Abstract][Full Text] [Related]
5. Drug courts: a primer for the family physician.
Lessenger JE; Roper GF
J Am Board Fam Pract; 2002; 15(4):298-303. PubMed ID: 12150463
[TBL] [Abstract][Full Text] [Related]
6. Specialty courts: Who's in and are they working?
Morgan RD; Mitchell SM; Thoen MA; Campion K; Bolaños AD; Sustaíta MA; Henderson S
Psychol Serv; 2016 Aug; 13(3):246-253. PubMed ID: 27504644
[TBL] [Abstract][Full Text] [Related]
7. Methodological, ethical, and legal considerations in drug court research.
DeMatteo D; Filone S; Laduke C
Behav Sci Law; 2011; 29(6):806-20. PubMed ID: 21971950
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on the drug court model across systems: a process evaluation.
Wolfe EL; Guydish J; Woods W; Tajima B
J Psychoactive Drugs; 2004 Sep; 36(3):379-86. PubMed ID: 15559684
[TBL] [Abstract][Full Text] [Related]
9. Integrating the criminal justice system into mental health service delivery: the worcester diversion experience.
Grudzinskas AJ; Clayfield JC; Roy-Bujnowski K; Fisher WH; Richardson MH
Behav Sci Law; 2005; 23(2):277-93. PubMed ID: 15818600
[TBL] [Abstract][Full Text] [Related]
10. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
[TBL] [Abstract][Full Text] [Related]
11. Los Angeles County drug court programs: initial results.
Fielding JE; Tye G; Ogawa PL; Imam IJ; Long AM
J Subst Abuse Treat; 2002 Oct; 23(3):217-24. PubMed ID: 12392808
[TBL] [Abstract][Full Text] [Related]
12. Examining the Impact of Prior Criminal Justice History on 2-Year Recidivism Rates: A Comparison of Drug Court Participants and Program Referrals.
Shannon LM; Jackson Jones A; Newell J; Neal C
Int J Offender Ther Comp Criminol; 2018 Feb; 62(2):291-312. PubMed ID: 27125834
[TBL] [Abstract][Full Text] [Related]
13. Augmenting substance use treatment in the drug court: A pilot randomized trial of peer recovery support.
Belenko S; LaPollo AB; Gesser N; Weiland D; Perron L; Johnson ID
J Subst Abuse Treat; 2021 Dec; 131():108581. PubMed ID: 34366204
[TBL] [Abstract][Full Text] [Related]
14. Juvenile drug treatment courts in the United States: initial lessons learned and issues being addressed.
Cooper CS
Subst Use Misuse; 2002; 37(12-13):1689-722. PubMed ID: 12487239
[TBL] [Abstract][Full Text] [Related]
15. Using latent class analysis to identify participant typologies in a drug treatment court.
Larsen JL; Nylund-Gibson K; Cosden M
Drug Alcohol Depend; 2014 May; 138():75-82. PubMed ID: 24598121
[TBL] [Abstract][Full Text] [Related]
16. Drug courts: current issues and future perspectives.
Cooper CS
Subst Use Misuse; 2003; 38(11-13):1671-711. PubMed ID: 14582574
[TBL] [Abstract][Full Text] [Related]
17. Problem-solving courts in Canada: A review and a call for empirically-based evaluation methods.
Slinger E; Roesch R
Int J Law Psychiatry; 2010; 33(4):258-64. PubMed ID: 20663560
[TBL] [Abstract][Full Text] [Related]
18. A multisite description of juvenile drug courts: program models and during-program outcomes.
Hiller ML; Malluche D; Bryan V; DuPont ML; Martin B; Abensur R; Leukefeld C; Payne C
Int J Offender Ther Comp Criminol; 2010 Apr; 54(2):213-35. PubMed ID: 19106251
[TBL] [Abstract][Full Text] [Related]
19. Tensions and contradictions in family court innovation with high risk parents: The place of family drug treatment courts in contemporary family justice.
Harwin J; Broadhurst K; Cooper C; Taplin S
Int J Drug Policy; 2019 Jun; 68():101-108. PubMed ID: 31130174
[TBL] [Abstract][Full Text] [Related]
20. Juvenile drug courts: emerging outcomes and key research issues.
Henggeler SW
Curr Opin Psychiatry; 2007 May; 20(3):242-6. PubMed ID: 17415076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
